# Electrophysiological Optimization of Left Ventricular Lead Placement in CRT

Study · id `cardio:ct-nct02346097` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02346097](<https://clinicaltrials.gov/study/NCT02346097>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02346097

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 122 participants.

## Technical summary

Registry record NCT02346097. Randomized; quadruple masking; primary purpose treatment. Start 2015-02-16 (actual); primary completion 2018-06-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 122 participants (enrolled count; ClinicalTrials.gov record NCT02346097, source copy `cardio:ctgov-nct02346097-2018-06-18`, retrieved 2026-10-26)
- Started: 2015-02-16 (actual) (ClinicalTrials.gov record NCT02346097, source copy `cardio:ctgov-nct02346097-2018-06-18`, retrieved 2026-10-26)
- Primary completion: 2018-06-07 (actual) (ClinicalTrials.gov record NCT02346097, source copy `cardio:ctgov-nct02346097-2018-06-18`, retrieved 2026-10-26)
- Completion: 2018-06-07 (actual) (ClinicalTrials.gov record NCT02346097, source copy `cardio:ctgov-nct02346097-2018-06-18`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT02346097, source copy `cardio:ctgov-nct02346097-2018-06-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02346097-2018-06-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Electrophysiological Optimization of Left Ventricular Lead Placement in CRT
- Acronym: ElectroCRT
- Condition: Congestive Heart Failure
- Intervention (Device): Cardiac Resynchronization Therapy (St. Jude Qaudripolar LV lead)
- Lead sponsor: University of Aarhus
- Lead sponsor class: OTHER
- Collaborator: Aarhus University Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: University of Aarhus (`cardio:org-university-of-aarhus`)
- Registry lists this organization as a collaborator: Aarhus University Hospital (`cardio:org-aarhus-university-hospital`)

## Provenance

Content hash: a3615395d35d4d3604b4bb491c298275ca2ff7e5fd21eac65a0361c5a044b67a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
